Furthermore, reduced activity of dihydropyrimidine dehydrogenase (DPD) is reported to associate with colorectal and hepatocellular carcinoma, which could lead to decrease uracil catabolism18, 53. Here, DPYD is linked to hepatocellular carcinoma.